Gut Liver.
2020 Mar;14(2):168-178. 10.5009/gnl19069.
Extrahepatic Manifestations of Nonalcoholic Fatty Liver Disease
- Affiliations
-
- 1Department of Medicine, Stanford University School of Medicine, Stanford, CA, USA
- 2Division of Gastroenterology and Hepatology, Stanford University School of Medicine, Stanford, CA, USA
- KMID: 2508726
- DOI: http://doi.org/10.5009/gnl19069
Abstract
- Nonalcoholic fatty liver disease (NAFLD) is the most common chronic liver disease and encompasses a spectrum of pathology from simple steatosis to inflammation and significant fibrosis that leads to cirrhosis. NAFLD and its comorbid conditions extend well beyond the liver. It is a multisystemic clinical disease entity with extrahepatic manifestations such as cardiovascular disease, type 2 diabetes, chronic kidney disease, hypothyroidism, polycystic ovarian syndrome, and psoriasis. Indeed, the most common causes of mortality in subjects with NAFLD are cardiovascular disease, followed by malignancies and then liver-related complications as a distant third. This review focuses on several of the key extrahepatic manifestations of NAFLD and areas for future investigation. Clinicians should learn to screen and initiate treatment for these extrahepatic manifestations in a prompt and timely fashion before they progress to end-organ damage.
- Full Text Links
-
- Actions
-
Cited
- CITED
-
- Close
- Share
-
- Similar articles
-
- Evaluation and management of extrahepatic manifestations of nonalcoholic fatty liver disease
- Noninvasive serum biomarkers for liver steatosis in nonalcoholic fatty liver disease: Current and future developments
- Nonalcoholic fatty liver disease: pathogenesis and treatment
- Elevated serum bilirubin levels are inversely associated with nonalcoholic fatty liver disease
- The crosstalk between insulin resistance and nonalcoholic fatty liver disease/metabolic dysfunction-associated fatty liver disease: a culprit or a consequence?
